Anti-KLC1 monoclonal antibody
Pre-made anti-KLC1 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research
Go to KLC1/KLC1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)
Product information
Catalog No. | Product Name | Species Reactivity |
---|---|---|
GM-Tg-hg-IP2564-Ab-1/ GM-Tg-hg-IP2564-Ab-2 | Anti-Human KLC1 monoclonal antibody | Human |
GM-Tg-rg-IP2564-Ab-1/ GM-Tg-rg-IP2564-Ab-2 | Anti-Rat KLC1 monoclonal antibody | Rat |
GM-Tg-mg-IP2564-Ab-1/ GM-Tg-mg-IP2564-Ab-2 | Anti-Mouse KLC1 monoclonal antibody | Mouse |
GM-Tg-cynog-IP2564-Ab-1/ GM-Tg-cynog-IP2564-Ab-2 | Anti-Cynomolgus/ Rhesus macaque KLC1 monoclonal antibody | Cynomolgus/ Rhesus macaque |
GM-Tg-felg-IP2564-Ab-1/ GM-Tg-felg-IP2564-Ab-2 | Anti-Feline KLC1 monoclonal antibody | Feline |
GM-Tg-cang-IP2564-Ab-1/ GM-Tg-cang-IP2564-Ab-2 | Anti-Canine KLC1 monoclonal antibody | Canine |
GM-Tg-bovg-IP2564-Ab-1/ GM-Tg-bovg-IP2564-Ab-2 | Anti-Bovine KLC1 monoclonal antibody | Bovine |
GM-Tg-equg-IP2564-Ab-1/ GM-Tg-equg-IP2564-Ab-2 | Anti-Equine KLC1 monoclonal antibody | Equine |
Size: 1mg | 10mg | 100mg
Product Description
Catalog No. | GM-Tg-hg-IP2564-Ab-1/ GM-Tg-hg-IP2564-Ab-2; GM-Tg-rg-IP2564-Ab-1/ GM-Tg-rg-IP2564-Ab-2; GM-Tg-mg-IP2564-Ab-1/ GM-Tg-mg-IP2564-Ab-2; GM-Tg-cynog-IP2564-Ab-1/ GM-Tg-cynog-IP2564-Ab-2; GM-Tg-felg-IP2564-Ab-1/ GM-Tg-felg-IP2564-Ab-2; GM-Tg-cang-IP2564-Ab-1/ GM-Tg-cang-IP2564-Ab-2; GM-Tg-bovg-IP2564-Ab-1/ GM-Tg-bovg-IP2564-Ab-2; GM-Tg-equg-IP2564-Ab-1/ GM-Tg-equg-IP2564-Ab-2 |
Products Name | Anti-KLC1 monoclonal antibody |
Format | mab |
Target Name | KLC1 |
Protein Sub-location | Introcelluar Protein |
Category of antibody | |
Derivation (species) | Mouse |
CH1+2+3 Isotype (Receptor identification) | IgG |
Type of Light Chain (VD-LC) | N/A |
Expression platform | Mammalian Expression |
Bioactivity validation | Binding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected. |
Tag | Fc |
Products description | Pre-made anti-KLC1 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
Category | Cat No. | Products Name |
Target Antigen | GM-Tg-g-IP2564-Ag-1 | Recombinant multi-species KLC1/ KLC/ KNS2 protein |
Target information
Target ID | GM-IP2564 |
Target Name | KLC1 |
Gene ID | 3831,16593,171041,695677,100855591,101099130,508999,100055290 |
Gene Symbol and Synonyms | KLC,KLC1,KNS2,KNS2A |
Uniprot Accession | Q07866,P37285 |
Uniprot Entry Name | KLC1_HUMAN,KLC1_RAT |
Protein Sub-location | Introcelluar Protein |
Category | |
Disease | Prostate Cancer |
Gene Ensembl | ENSG00000126214 |
Target Classification | N/A |
The target: KLC1, gene name: KLC1, also named as KLC, KNS2, KNS2A. Conventional kinesin is a tetrameric molecule composed of two heavy chains and two light chains, and transports various cargos along microtubules toward their plus ends. The heavy chains provide the motor activity, while the light chains bind to various cargos. This gene encodes a member of the kinesin light chain family. It associates with kinesin heavy chain through an N-terminal domain, and six tetratricopeptide repeat (TPR) motifs are thought to be involved in binding of cargos such as vesicles, mitochondria, and the Golgi complex. Thus, kinesin light chains function as adapter molecules and not motors per se. Although previously named "kinesin 2", this gene is not a member of the kinesin-2 / kinesin heavy chain subfamily of kinesin motor proteins. Extensive alternative splicing produces isoforms with different C-termini that are proposed to bind to different cargos; however, the full-length nature and/or biological validity of most of these variants have not been determined. [provided by RefSeq, Jul 2008].
About Gmab
GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.